H.R. 4837 requires the Department of Veterans Affairs to expand its existing informed consent requirements to cover a broader range of medications used to treat veterans. Currently, the VA's informed consent directive only applies to long-term opioid therapy for pain, but this bill would extend those same requirements to antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. This means veterans would need to receive and sign written informed consent documentation before starting these medications, ensuring they understand the benefits, risks, and alternatives. The bill affects all veterans receiving care through the VA health system and does not include specific funding amounts or implementation timelines, leaving those details to the Secretary of Veterans Affairs to determine.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.